Invitro Genetics Limited
09901425
Healthy
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/10/2025
full
Next accounts due
31/07/2027
Confirmation statement
Last: 01/07/2026
Due 15/07/2027
Industry
Officers
director · Since 02/10/2017
CORPORATE EXECUTIVE
AMERICAN · UNITED STATES · Age 59
Also on 13 other boards
Mr Michael John Good
director · Since 03/08/2026
AMERICAN · UNITED STATES · Age 47
Former
director · Resigned 03/08/2026
Persons with Significant Control
Coopersurgical Holdings Limited
Delta Park, Concorde Way, Fareham, PO15 5RL
Reg: 9877160 · England And Wales · Private Company Limited By Shares
Notified 06/04/2016
CompanyRankvs 1859+ SIC 86220 peers68
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
the company and assessed the company’s ability to continue to meet its liabilities as they fall due for a period of at least 12 months from the date of approval of these financial statements (the “going concern assessment period”). The company is a subsidiary of The Cooper Companies, which operates the Cooper Surgical Worldwide business which has been innovating in the fertility and women’s health
Key FinancialsYear ending 31/10/2025
Turnover
£9.0M
Annual revenue
Net Worth
£2.2M
Balance sheet strength
Cash
£695k
Cash in the bank
Profit Before Tax
£2.5M
Bottom line earnings
Net Current Assets
£799k
Working capital
Current Assets
£2.8M
Current Liabilities
£2.0M
Fixed Assets
£1.5M
Debtors
£1.7M
Cost of Sales
£3.5M
Gross Profit
£5.5M
Admin Expenses
£2.9M
Profit After Tax
£1.9M
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.41 | +£1.9M |
| 2022 | 0.70 | -£240k |
| 2021 | 0.72 | — |
Derived from filed accounts. Not audited figures.